GlassScriptPhysician profile
Derek P Jacobsen
NPI 1124462593
$4,221.33
in general payments reported to CMS, 2019-2025
17 companies · $502 in 2025
The $502 reported for 2025 was more than what 77% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.26 · 2020: $19.99 · 2021: $343 · 2022: $451 · 2023: $2,022 · 2024: $822 · 2025: $502.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,134 · Consulting Fee: $1,188 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,133.55 |
| Consulting Fee | $1,187.50 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $1,762.18 | 2022-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Bausch & Lomb Americas INC. | $530.36 | 2022-2025 | Ic-8 Apthera Iol, Envista Mx60 Iol, Vyzulta |
| Biotissue Holdings INC. | $343.63 | 2023-2024 | |
| Alcon Vision LLC | $236.64 | 2022-2025 | Tryptyr, Eysuvis, Precision 1 |
| Sun Pharmaceutical Industries INC. | $226.20 | 2019-2024 | Bromsite, Cequa, Xelpros |
| Glaukos Corporation | $221.93 | 2025 | Istent Infinite |
| Coopervision INC. | $205.62 | 2024-2025 | Myday Contact Lens, Clariti Contact Lens |
| Tarsus Pharmaceuticals, INC. | $160.40 | 2024-2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $150.75 | 2021 | |
| Oyster Point Pharma, INC. | $109.07 | 2023-2024 | Tyrvaya, Ryzumvi |
| Ivantis, INC | $93.00 | 2021 | |
| Thea Pharma INC. | $56.50 | 2022-2025 | Iyuzeh |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $35.16 | 2020-2021 | |
| Abbvie INC. | $32.91 | 2024 | |
| Novartis Pharmaceuticals Corporation | $24.17 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| The Cameron-Ehlen Group, INC. | $17.42 | 2021 | |
| Eyevance Pharmaceuticals LLC | $15.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Jacobsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.